The role of the neutral amino acid transporter B0AT1 (SLC6A19) in hartnup disorder and protein nutrition

97Citations
Citations of this article
98Readers
Mendeley users who have this article in their library.

Abstract

Hartnup disorder (OMIM 234500) is an autosomal recessive disorder, which was first described in 1956 as an aminoaciduria of neutral amino acids accompanied by a variety of symptoms, such as a photo-sensitive skin-rash and cerebellar ataxia. The disorder is caused by mutations in the neutral amino acid transporter B0AT1 (SLC6A19)1. To date 21 mutations have been identified in more than twenty families. SLC6A19 requires either collectrin or angiotensin-converting enzyme 2 for surface expression in the kidney and intestine, respectively. This ties SLC6A19 together with more complex functions such as blood-pressure control, glomerular structure, and exocytosis. © 2009 IUBMB.

Cite

CITATION STYLE

APA

Bröer, S. (2009). The role of the neutral amino acid transporter B0AT1 (SLC6A19) in hartnup disorder and protein nutrition. IUBMB Life. https://doi.org/10.1002/iub.210

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free